AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ABBV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.76%126.280.6%$998.44m
PFEPfizer Inc.
0.63%34.471.9%$822.98m
BMYBristol-Myers Squibb Company
1.15%56.352.8%$690.02m
MRKMerck & Co., Inc.
-0.64%63.500.6%$573.70m
ABBVAbbVie, Inc.
0.25%65.511.9%$452.35m
LLYEli Lilly and Company
0.75%84.361.1%$329.60m
NVSNovartis AG Sponsored ADR
-0.26%74.200.2%$230.29m
AZNAstraZeneca PLC Sponsored ADR
2.01%30.981.1%$143.80m
GSKGlaxoSmithKline plc Sponsored ADR
-0.10%42.280.3%$124.02m
NVONovo Nordisk A/S Sponsored ADR Class B
0.74%33.930.1%$73.47m
SNYSanofi Sponsored ADR
0.71%44.680.2%$66.72m
LCILannett Company, Inc.
0.24%20.8536.7%$15.27m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.94%10.7515.6%$13.56m
AKTXAkari Therapeutics Plc Sponsored ADR
0.46%6.530.1%$0.12m
EPIXESSA Pharma Inc
2.16%3.310.0%$0.03m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.